drugset / Trial / NCT03963115

Can Epinephrine Coated Syringe for Subcutaneous Immunotherapy (SCIT) Reduce Large Local Reaction?

NCT03963115

Phase 1/2 Completed 17 enrolled Mahidol University
RandomizedCrossoverQuadruple-blindTreatment

Summary

Allergen immunotherapy is effective in the management of allergic asthma, allergic rhinitis/conjunctivitis, and stinging insect hypersensitivity. The most common side effect of subcutaneous allergen specific immunotherapy (SCIT) is local reactions (LR). Although some studies indicated that LR did not predict systemic reaction (SR), patients with higher frequency of large local reaction (LLR) were reported to have higher risk for SR. Epinephrine may decrease LLR due to its vasoconstrictive effect . The objective of this study was to compare the size of LLR in patients receiving SCIT with epinephrine or normal saline coated syringe. The patients who complained of frequent LLR despite pre-medication and local treatment were recruited.

Timeline

Start
2018-10-24
Primary completion
2019-08-25
Completion
2019-09-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Epinephrine Other / unclassified